BRIEF published on 11/22/2024 at 07:05, 1 year 7 months ago SoftwareOne Finalizes CHF 70 Million Share Buyback Initiative Share Buyback Shareholder Approval SoftwareOne SIX Swiss Exchange Cloud Solutions
BRIEF published on 11/22/2024 at 07:05, 1 year 7 months ago SoftwareOne finalise son programme de rachat d'actions pour un montant de 70 millions de francs suisses Rachat D'actions Solutions Cloud Approbation Des Actionnaires LogicielOne Bourse Suisse SIX
BRIEF published on 11/22/2024 at 07:05, 1 year 7 months ago First Berlin Raises beaconsmind AG Price Target Amid Strategic Acquisitions Acquisitions Price Target SaaS Solutions Beaconsmind AG First Berlin
BRIEF published on 11/22/2024 at 07:05, 1 year 7 months ago First Berlin relève son objectif de cours pour beaconsmind AG dans le cadre d'acquisitions stratégiques Acquisitions Solutions SaaS Objectif De Prix Beaconsmind AG Premier Berlin
BRIEF published on 11/22/2024 at 06:50, 1 year 7 months ago Komax Group's Strategic Progress Amidst Market Challenges Operational Efficiency Market Expansion Revenue Targets China Market Komax Strategy
BRIEF published on 11/22/2024 at 06:50, 1 year 7 months ago Progrès stratégique du groupe Komax face aux défis du marché Efficacité Opérationnelle Objectifs De Revenus Marché Chinois Expansion Du Marché Stratégie Komax
BRIEF published on 11/22/2024 at 00:05, 1 year 7 months ago Gratomic Provides Update on Aukam Graphite Mine and Board Changes Graphite Supply Gratomic Aukam Graphite Mine Hermanus Manuel Silver Kobus La Grange
BRIEF published on 11/22/2024 at 00:05, 1 year 7 months ago Gratomic fournit des informations actualisées sur la mine de graphite d'Aukam et les changements au sein du conseil d'administration Approvisionnement En Graphite Gratomique Hermanus Manuel Silver Kobus La Grange Mine De Graphite D'Aukam
BRIEF published on 11/21/2024 at 22:10, 1 year 7 months ago Protagonist Therapeutics Nominates PN-881 for Immune-Mediated Skin Disorders Protagonist Therapeutics IL-17 Antagonist PN-881 Skin Diseases Phase I Trials
BRIEF published on 11/21/2024 at 22:10, 1 year 7 months ago Protagonist Therapeutics nomme le PN-881 pour le traitement des troubles cutanés à médiation immunitaire Thérapeutique Protagoniste Antagoniste De L'IL-17 PN-881 Maladies De La Peau Essais De Phase I
Published on 06/30/2026 at 00:05, 28 minutes ago American Critical Minerals Announces Completion of Warrant Exercise Incentive Program
Published on 06/29/2026 at 23:46, 47 minutes ago 1933 Industries Reports Third Quarter 2026 Financial Results
Published on 06/29/2026 at 22:01, 2 hours 32 minutes ago AIP Realty Trust Announces Voting Results of Annual General and Special Meeting of Unitholders
Published on 06/29/2026 at 15:00, 9 hours 33 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 15:00, 9 hours 33 minutes ago Vox Royalty Highlights Significant Gold Offtake-Stream Exposure to Los Filos Following Key Milestone Announcement
Published on 06/29/2026 at 22:47, 1 hour 46 minutes ago Correction d’un communiqué du 29.06.2026 22:05 CET/CEST - ABIVAX: Résultats positifs de la partie 2 de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les ...
Published on 06/29/2026 at 22:05, 2 hours 28 minutes ago ABIVAX: Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
Published on 06/29/2026 at 22:05, 2 hours 28 minutes ago Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
Published on 06/29/2026 at 20:30, 4 hours 3 minutes ago Shelly Group SE: Annual General Meeting approves dividend of EUR 0.13 per share – shareholders approve all agenda items
Published on 06/29/2026 at 20:00, 4 hours 33 minutes ago IGEL Appoints James Millington as Field CTO for Healthcare in EMEA
Published on 06/29/2026 at 18:30, 6 hours 3 minutes ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 6 hours 3 minutes ago Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
Published on 06/29/2026 at 17:45, 6 hours 48 minutes ago Succès de l’émission obligataire de 1,5 milliard d’euros
Published on 06/29/2026 at 17:45, 6 hours 48 minutes ago Déclaration hebdomadaire de rachat d'actions
